James Kasinger

Track

Insider profile

Currently holds a position at CRISPR Therapeutics AG

Performance

Overall performance
3.7
Performance over holding periods
3.7
30 days 90 days 120 days
Average return 11% 8.2% 15.1%
Success rate 82% 68% 82%
Transactions
14 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
General Counsel, Secretary CRISPR Therapeutics AG May 1, 2017 -
James Kasinger's trades of CRISPR Therapeutics AG's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
399.59
Quantity 87,832
Value US$4,656,906
Transaction date
Proposed sale
Price
60.24
Quantity 10,400
Value US$626,460
Transaction date
Planned sale
Price
205.60
Quantity 8,997 -25.5%
Value US$1,849,783
Transaction date
Planned sale
Price
204.40
Quantity 7,818 -18.1%
Value US$1,597,999
Transaction date
Planned sale
Price
203.58
Quantity 6,785 -13.6%
Value US$1,381,290
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-10-15 2026-10-14
S Sale
8,325 -3.6%
443.76
US$3,497,884 		8,325 -3.6% 443.76 US$3,497,884
2026-10-08 2026-10-06
PlS Planned sale
14,882 +10.5%
41.46
US$591,785 		14,882 +10.5% 41.46 US$591,785
2026-10-06 2026-10-06
PrS Proposed sale
87,832
399.59
US$4,656,906 		87,832 399.59 US$4,656,906
2026-09-24 2026-09-22
PlS Planned sale
10,400 -9.9%
60.24
US$626,460 		10,400 -9.9% 60.24 US$626,460
2026-09-22 2026-09-22
PrS Proposed sale
10,400
60.24
US$626,460 		10,400 60.24 US$626,460
2026-03-24 2026-03-23
S Sale
3,182 -3.3%
46.78
US$148,854 		3,182 -3.3% 46.78 US$148,854
2026-03-17 2026-03-16
S Sale
3,450 -3.6%
48.26
US$166,497 		3,450 -3.6% 48.26 US$166,497
2026-03-12 2026-03-11
S Sale
2,800 -3.1%
52.80
US$147,840 		2,800 -3.1% 52.80 US$147,840
2026-02-20 2026-02-19
S Sale
2,112 -2.4%
52.58
US$111,049 		2,112 -2.4% 52.58 US$111,049
2025-10-15 2025-10-14
S Sale
1,076 -1.3%
66.60
US$71,662 		1,076 -1.3% 66.60 US$71,662
2025-03-24 2025-03-21
S Sale
3,185 -3.8%
41.23
US$131,318 		3,185 -3.8% 41.23 US$131,318
2025-03-12 2025-03-12
S Sale
1,116 -1.4%
43.32
US$48,345 		1,116 -1.4% 43.32 US$48,345
2025-03-12 2025-03-11
S Sale
2,850 -3.5%
42.42
US$120,897 		2,850 -3.5% 42.42 US$120,897
2025-02-19 2025-02-19
S Sale
1,947 -2.5%
52.80
US$102,802 		1,947 -2.5% 52.80 US$102,802
2025-02-19 2025-02-18
S Sale
9,595 -11.6%
53.85
US$516,691 		9,595 -11.6% 53.85 US$516,691
2024-10-15 2024-10-14
S Sale
1,089 -1.7%
46.28
US$50,399 		1,089 -1.7% 46.28 US$50,399
2024-03-12 2024-03-12
S Sale
1,146 -1.8%
74.44
US$85,308 		1,146 -1.8% 74.44 US$85,308
2024-03-12 2024-03-11
S Sale
2,801 -4.5%
78.26
US$219,206 		2,801 -4.5% 78.26 US$219,206
2024-02-21 2024-02-20
S Sale
1,913 -3.2%
79.67
US$152,409 		1,913 -3.2% 79.67 US$152,409
2021-01-20 2021-01-19
PlS Planned sale
2,100 -8.6%
207.61
US$435,981 		2,100 -8.6% 207.61 US$435,981
2021-01-20 2021-01-19
PlS Planned sale
1,800 -6.8%
206.05
US$370,890 		1,800 -6.8% 206.05 US$370,890
2021-01-20 2021-01-19
PlS Planned sale
8,997 -25.5%
205.60
US$1,849,783 		8,997 -25.5% 205.60 US$1,849,783
2021-01-20 2021-01-19
PlS Planned sale
7,818 -18.1%
204.40
US$1,597,999 		7,818 -18.1% 204.40 US$1,597,999
2021-01-20 2021-01-19
PlS Planned sale
6,785 -13.6%
203.58
US$1,381,290 		6,785 -13.6% 203.58 US$1,381,290